HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Ashton Selected Research

R116301

8/2002Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Ashton Research Topics

Disease

1Weight Loss (Weight Reduction)
10/2014
1Cough
08/2002
1Edema (Dropsy)
08/2002
1Miosis
08/2002
1Prostatic Neoplasms (Prostate Cancer)
12/2001
1Adenocarcinoma
12/2001
1Schizophrenia (Dementia Praecox)
12/2001

Drug/Important Bio-Agent (IBA)

1Insulin (Novolin)FDA Link
10/2014
1Capsaicin (Zostrix)FDA Link
08/2002
1Neurokinin-3 ReceptorsIBA
08/2002
1senktideIBA
08/2002
1R116301IBA
08/2002
1Neurokinin AIBA
08/2002
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
08/2002
1NK 2 (NK-2)IBA
08/2002
1Prostate-Specific Antigen (Semenogelase)IBA
12/2001
1AntioxidantsIBA
12/2001
1LycopeneIBA
12/2001
1Pharmaceutical PreparationsIBA
12/2001

Therapy/Procedure

2Therapeutics
10/2014 - 12/2001
1Prostatectomy (Retropubic Prostatectomy)
12/2001